Two Sigma Securities’s Microbot Medical MBOT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-10,613
Closed -$21.2K 1970
2025
Q4
$21.2K Sell
10,613
-19,529
-65% -$46.3K ﹤0.01% 1170
2025
Q3
$91.9K Buy
+30,142
New +$94K 0.01% 915
2025
Q2
Sell
-14,823
Closed -$22.4K 1844
2025
Q1
$22.4K Buy
14,823
+4,095
+38% +$7.24K ﹤0.01% 1085
2024
Q4
$12K Buy
10,728
+56
+0.5% +$55 ﹤0.01% 1413
2024
Q3
$9.54K Sell
10,672
-768
-7% -$748 ﹤0.01% 2596
2024
Q2
$11.7K Sell
11,440
-3,543
-24% -$3.64K ﹤0.01% 2788
2024
Q1
$18.4K Sell
14,983
-5,276
-26% -$6.69K ﹤0.01% 2684
2023
Q4
$33.2K Buy
+20,259
New +$27K ﹤0.01% 2650
2018
Q2
Sell
-3,222
Closed -$33K 2866
2018
Q1
$33K Buy
3,222
+2,398
+291% +$32.4K ﹤0.01% 2536
2017
Q4
$13K Sell
824
-899
-52% -$15.3K ﹤0.01% 1661
2017
Q3
$30K Buy
1,723
+87
+5% +$1.53K ﹤0.01% 784
2017
Q2
$35K Buy
+1,636
New +$90.3K 0.01% 739
2016
Q2
Sell
-36
Closed -$15K 481
2016
Q1
$15K Buy
+36
New +$19K 0.02% 248
2015
Q4
Sell
-21
Closed -$14K 334
2015
Q3
$14K Buy
+21
New +$16K 0.02% 191
2015
Q2
Sell
-11
Closed -$17K 228
2015
Q1
$17K Buy
+11
New +$19.6K 0.02% 182

Other funds holding MBOT

Two Sigma Securities's MBOT Position: Q1 2026 in Review

Two Sigma Securities sold out of Microbot Medical (MBOT) in Q1 2026, closing a stake of 10,613 shares — an estimated $21.2K sold.

Two Sigma Securities first reported a position in MBOT in Q1 2015 and held it in 15 quarters. The position peaked at $91.9K in Q3 2025. 79 funds tracked by Wall St. Rank hold MBOT as of Q1 2026.

  • Two Sigma Securities reported no remaining Microbot Medical position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Securities sold 10,613 Microbot Medical shares in Q1 2026, an estimated $21.2K.
  • Two Sigma Securities first reported a position in Microbot Medical in Q1 2015 and held it in 15 quarters.
  • Two Sigma Securities's Microbot Medical position peaked at $91.9K in Q3 2025.
  • 79 funds tracked by Wall St. Rank held Microbot Medical as of Q1 2026.

Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.